| Dr Penporn Vongsvivut Reck, MD | |
|
345 College St Se, Suite C, Lacey, WA 98503-1014 | |
| (360) 456-3200 | |
| (360) 456-3894 |
| Full Name | Dr Penporn Vongsvivut Reck |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 22 Years |
| Location | 345 College St Se, Lacey, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811919871 | NPI | - | NPPES |
| 8511552 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD00049407 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Physicians Of Olympia Inc Ps | 8123916962 | 13 |
News Archive
Xiaowei Dong, Associate Professor and P1 Curriculum Director at HSC College of Pharmacy, was recently awarded the Maximizing Investigators' Resource Award (MIRA-R35) to continue her research into technologies that improve the effectiveness of oral drugs.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
Intestinal flora has multiple influences on human health, but researchers have revealed that it is also likely to have an effect on the body's response to drugs.
The invasion of brain-tumor cells into surrounding tissue requires the same protein molecule that neurons need to migrate into position as they differentiate and mature, according to new research from the University of Illinois at Chicago College of Medicine and published August 7 in the online journal PLOS ONE.
The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007, according to a new study published in The Oncologist, funded by the National Cancer Institute and led by Kaiser Permanente Colorado.
› Verified 5 days ago
| Entity Name | Eye Physicians Of Olympia Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821165911 PECOS PAC ID: 8123916962 Enrollment ID: O20040308000701 |
News Archive
Xiaowei Dong, Associate Professor and P1 Curriculum Director at HSC College of Pharmacy, was recently awarded the Maximizing Investigators' Resource Award (MIRA-R35) to continue her research into technologies that improve the effectiveness of oral drugs.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
Intestinal flora has multiple influences on human health, but researchers have revealed that it is also likely to have an effect on the body's response to drugs.
The invasion of brain-tumor cells into surrounding tissue requires the same protein molecule that neurons need to migrate into position as they differentiate and mature, according to new research from the University of Illinois at Chicago College of Medicine and published August 7 in the online journal PLOS ONE.
The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007, according to a new study published in The Oncologist, funded by the National Cancer Institute and led by Kaiser Permanente Colorado.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Penporn Vongsvivut Reck, MD 345 College St Se, Suite C, Lacey, WA 98503-1014 Ph: (360) 456-3200 | Dr Penporn Vongsvivut Reck, MD 345 College St Se, Suite C, Lacey, WA 98503-1014 Ph: (360) 456-3200 |
News Archive
Xiaowei Dong, Associate Professor and P1 Curriculum Director at HSC College of Pharmacy, was recently awarded the Maximizing Investigators' Resource Award (MIRA-R35) to continue her research into technologies that improve the effectiveness of oral drugs.
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
Intestinal flora has multiple influences on human health, but researchers have revealed that it is also likely to have an effect on the body's response to drugs.
The invasion of brain-tumor cells into surrounding tissue requires the same protein molecule that neurons need to migrate into position as they differentiate and mature, according to new research from the University of Illinois at Chicago College of Medicine and published August 7 in the online journal PLOS ONE.
The use of an injectable, clot-preventing drug known as Low Molecular Weight Heparin to treat patients with advanced cancer complicated by blood clots increased steadily between 2000 and 2007, according to a new study published in The Oncologist, funded by the National Cancer Institute and led by Kaiser Permanente Colorado.
› Verified 5 days ago
Dr. Stephen D Reck, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 345 College St Se, Suite C, Lacey, WA 98503 Phone: 360-456-3200 Fax: 360-456-3894 | |
Dr. Jay Charles Rudd, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 345 College St Se, Suite C, Lacey, WA 98503 Phone: 360-456-3200 Fax: 360-456-3894 | |
Dr. Gary Neal Scholes, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 345 College St Se, Suite C, Lacey, WA 98503 Phone: 360-456-3200 Fax: 360-456-3894 |